---
title: Immune signature of patients with cardiovascular disease predicts increased
  risk for a severe course of COVID-19
date: '2024-08-02'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39094122/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240803181444&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: Severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) infection
  can lead to life-threatening clinical manifestations. Patients with cardiovascular
  disease (CVD) are at higher risk for severe courses of COVID-19. So far, however,
  there are hardly any strategies for predicting the course of SARS-CoV-2 infection
  in CVD patients at hospital admission. Thus, we investigated whether this prediction
  is achievable by prospectively analysing the blood immunophenotype of 94 ...
disable_comments: true
---
Severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) infection can lead to life-threatening clinical manifestations. Patients with cardiovascular disease (CVD) are at higher risk for severe courses of COVID-19. So far, however, there are hardly any strategies for predicting the course of SARS-CoV-2 infection in CVD patients at hospital admission. Thus, we investigated whether this prediction is achievable by prospectively analysing the blood immunophenotype of 94 ...